Back

HFpEF: cardiomyocyte dysfunction and the stiff heart.

28 August 2017 (11:00 - 11:22)
Organised by:
Congress Presentation Part of: Mechanisms of Heart Failure with preserved Ejection Fraction - Implications for treatment Growth factors, neurohormones and signal transduction-cardiac ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Wolfgang Linke

University Hospital Munster - UKM, Muenster (Germany)

3 More presentations in this session

Presentation thumbnail
HFpEF: fibroblast dysfunction and the stiff heart.
Professor J. Diez Martinez (Pamplona, ES)
Slides Video
Presentation thumbnail
HFpEF: the contribution of oxidative stress.
Professor A. Shah (London, GB)
Presentation thumbnail
HFpEF: the role of inflammation
Doctor V. van Empel (Maastricht, NL)
Slides Video

Access the full session

Session thumbnail
Mechanisms of Heart Failure with preserved Ejection Fraction - Implications for treatment

The Event

Event poster

ESC Congress 2017

28 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Imaging in heart failure: what about myocardial fibrosis?
31 August 2024
thumbnail
Congress Presentation
Cardiac myosin inhibitor, mavacamten, improves myocardial relaxation in mouse HFpEF model
30 April 2022
thumbnail
Congress Presentation
Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): rise in arterial stiffness associates with HFpEF with increase in comorbidities.
27 August 2021
thumbnail
Webinar
GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?
15 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources